Oncolytics Biotech Inc.

General ticker "ONCY" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $103.8M (TTM average)

Oncolytics Biotech Inc. does not follow the US Stock Market performance with the rate: -19.4%.

Estimated limits based on current volatility of 2.5%: low 0.84$, high 0.88$

Factors to consider:

  • Total employees count: 9 as of 2002
  • Company does not operate outside North America (retrieved using AI)
  • Top business risk factors: Insufficient capital, Clinical trial failure, Regulatory and compliance, Market competition, Market acceptance
  • Price in estimated range
  • Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [0.63$, 1.61$]
  • 2026-12-31 to 2027-12-31 estimated range: [0.56$, 1.45$]

Financial Metrics affecting the ONCY estimates:

  • Positive: with PPE of -4.2 at the end of fiscal year the price was neutral
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -16.44 <= 0.28
  • Negative: negative Net income
  • Positive: Investing cash flow per share per price, % of 0 > -0.64
  • Positive: Interest expense per share per price, % of 0 <= 0.01
  • Negative: negative Industry operating cash flow (median)

Similar symbols

Short-term ONCY quotes

Long-term ONCY plot with estimates

Financial data

YTD 2024-12-31 2025-12-31
Operating Revenue CA$0.00MM CA$0.00MM
Operating Expenses CA$25.54MM CA$28.73MM
Operating Income CA$-25.54MM CA$-28.73MM
Non-Operating Income CA$2.84MM CA$0.04MM
R&D Expense CA$15.44MM CA$13.31MM
Income(Loss) CA$-22.70MM CA$-28.68MM
Taxes CA$0.10MM CA$0.08MM
Net Income(Loss)* CA$-22.79MM CA$-28.76MM
Stockholders Equity CA$3.30MM CA$-3.80MM
Assets CA$13.42MM CA$7.58MM
Operating Cash Flow CA$-19.88MM CA$-20.11MM
Capital expenditure CA$0.17MM CA$0.01MM
Investing Cash Flow CA$-0.17MM CA$-0.01MM
Financing Cash Flow CA$5.03MM CA$14.12MM
Earnings Per Share** CA$-0.30 CA$-0.30

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.